RefluG Isorepair: the new experience for oesophageal mucosal defence

Published: 23-Jul-2020

RefluG Isorepair is a patented medical device (class IIa) with long-lasting action for the treatment of gastro-oesophageal reflux symptoms

Gastro-oesophageal reflux is a common disorder that happens when the stomach content flows back into the oesophagus and, due to its acidity and its irritant components, it may cause damage to the oesophageal mucosa, the appearance of lesions and symptoms such as acid regurgitation, burning, retrosternal pain and irritative cough.

RefluG Isorepair is designed to reduce gastroesophageal reflux symptoms by exerting multiple mechanical actions on the esophageal mucosa surface (protective, soothing, lubricant). It can be used both in combination with proton pump inhibitors and H2 antagonists, and it is available in ready-to-take liquid sachets.

Protective action able to promote repair processes of the esophageal mucosa thanks to the presence of hyaluronic acid and an amino acid complex (proline, hydroxyproline and glutamine). Thanks to its known water storage properties, hyaluronic acid creates a protective film on the oesophageal mucosa protecting it from damage. In addition, the synergistic effect of hyaluronic acid and amino acids favours the physiological repair processes of the oesophageal mucosa, which may be compromised in the event of gastro-oesophageal reflux.

Anti-irritative action promoted by the VGF plant complex which, with its emollient properties, helps to reduce irritation of the oesophageal mucosa. Lubricant action favoured by the filming effect of the medical device.

The efficacy, safety and tolerability of RefluG Isorepair has been proven and documented in clinical and preclinical trials confirming its ability to promote the natural repair processes of the oesophageal mucosa.

Discover RefluG Isorepair, a patented class IIa MD, ask for your free copy of the new leaflet.

RefluG Isorepair: the new experience for oesophageal mucosal defence

You may also like